US Broker Ratings

Atrium Therapeutics, Inc. (RNA) Stock Analysis: A Biotech Gem with a 201.57% Potential Upside

Atrium Therapeutics, Inc. (NASDAQ: RNA) is making waves in the biotechnology sector with its pioneering approach to RNA therapeutics aimed at combating cardiomyopathies. Headquartered in San..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Robust Growth Amid Market Volatility

Halozyme Therapeutics, Inc. (NASDAQ: HALO) stands out in the biotechnology sector with its impressive market cap of $12.93 billion, reflecting a strong presence in the healthcare..

Charles River Laboratories (CRL) Stock Analysis: Navigating Growth Potential Amidst Market Challenges

Charles River Laboratories International, Inc. (NYSE: CRL), a prominent player in the healthcare sector, is making waves in the diagnostics and research industry. With a market..

Axsome Therapeutics (AXSM) Investor Outlook: Exploring a 46% Potential Upside Amid Robust CNS Portfolio

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a prominent player in the biotechnology sector, is making waves with its innovative treatments targeting central nervous system (CNS) disorders. With..

Chemed Corp (CHE) Stock Analysis: Exploring a Potential 11.61% Upside in the Healthcare Sector

For investors seeking opportunities in the healthcare sector, Chemed Corporation (NYSE: CHE) emerges as an intriguing candidate. With a market capitalization of $6.69 billion, Chemed operates..

Repligen Corporation (RGEN) Stock Analysis: Navigating Growth with a Robust 11.9% Revenue Surge

Repligen Corporation (NASDAQ: RGEN), a prominent player in the healthcare sector, continues to capture investor interest with its innovative approach to bioprocessing technologies. Headquartered in Waltham,..

Krystal Biotech, Inc. (KRYS) Investor Outlook: Analyzing the 13.39% Potential Upside

Krystal Biotech, Inc. (NASDAQ: KRYS), a pivotal player in the biotechnology sector, is capturing investor attention with its impressive market cap of $10.24 billion and a..

Jazz Pharmaceuticals plc (JAZZ) Stock Analysis: A Promising Upside of 23% Driven by Robust Pipeline and Performance

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is emerging as a compelling opportunity for investors within the biotechnology sector. With a market capitalization of $15.45 billion, this Dublin-based..

AstraZeneca PLC (AZN): Investor Outlook with a 27% Potential Upside and Robust Analyst Confidence

AstraZeneca PLC (AZN), a leading player in the healthcare sector, has been capturing the attention of investors with its strong market presence and promising growth prospects...

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: A Deep Dive into 32% Potential Upside

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is drawing significant attention from investors, boasting a remarkable potential upside of 32.05% based on the average analyst target price. This..

DexCom, Inc. (DXCM) Rating Update: Strong Buy Ratings with a Potential Upside of 9.07%

DexCom, Inc. (NASDAQ: DXCM) continues to solidify its position as a leader in the healthcare industry, specifically within the medical devices sector. The company’s focus on..

Fresenius Medical Care AG (FMS) Stock Analysis: Navigating Growth Potential with an 11.50% Upside

Fresenius Medical Care AG (NYSE: FMS), a global leader in providing dialysis and related services, is capturing investor attention with its potential upside of 11.50%. As..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: Unveiling a 52% Potential Upside Amid Robust Revenue Growth

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a key player in the biotechnology sector specializing in therapies for rare diseases, presents an intriguing opportunity for investors looking to..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: Unveiling a 17.56% Potential Upside

Intuitive Surgical, Inc. (NASDAQ: ISRG), a luminary in the medical instruments and supplies industry, continues to capture investor attention with its innovative contributions to healthcare. Headquartered..

Viatris Inc. (VTRS) Stock Analysis: Exploring a 8.81% Potential Upside Amidst Healthcare Sector Dynamics

As investors navigate the complex landscape of the healthcare sector, Viatris Inc. (NASDAQ: VTRS) presents a compelling case for consideration, especially with its potential upside of..

Globus Medical, Inc. (GMED) Stock Analysis: A 38.53% Upside Potential in the Medical Devices Sector

Globus Medical, Inc. (NYSE: GMED) stands out in the healthcare sector, particularly in the medical devices industry, with a market cap of $10.01 billion. Specializing in..

Bruker Corporation (BRKR) Stock Analysis: Navigating Growth in the Medical Devices Sector with a 5.20% Revenue Surge

Bruker Corporation (NASDAQ: BRKR) stands out in the healthcare sector, particularly in the medical devices industry, with a remarkable market capitalization of $9.78 billion. Based in..

Stryker Corporation (SYK) Stock Analysis: Exploring a 35% Potential Upside with Strong Buy Ratings

Stryker Corporation (NYSE: SYK), a global leader in the medical technology sector, is drawing significant attention from investors, driven by its robust fundamentals and substantial growth..

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Unveiling a 35% Potential Upside

IDEXX Laboratories, Inc. (NASDAQ: IDXX) stands as a prominent player in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of..

West Pharmaceutical Services (WST) Stock Analysis: A Healthcare Giant with 10% Upside Potential

West Pharmaceutical Services, Inc. (NYSE: WST), a stalwart in the healthcare sector, stands as a formidable player in the medical instruments and supplies industry. With a..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds